French cancer charity charged with misuse of funds
This article was originally published in Clinica
Time may be running out for France's largest medical charity, the Association pour la Recherche sur le Cancer, after a leaked report suggested funds had been misused. The agency's president, Jacques Crozemarie, has threatened to shut the charity down after public auditors showed that only 27% of the charity's 1993 income of Fr 581 million ($119 million) was spent on cancer research. The report also questioned the real cost of the charity's fund-raising campaigns, overcharging by printers and unjustified payments.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.